Tamoxifen is a nonsteroidal triphenylethylene derivative that is currently used for the treatment for ER+ (estrogen receptor positive) breast cancer as a means of reducing recurrent breast cancer in breast cancer survivors (BC survivors) [1]–[6]. This evidence concerns the gene ESR1 and breast cancer.